THINKCYTE integrate optics, genomics and information science to create “machines” that uncover and understand high-resolution information from single cells, with the goal of moving healthcare beyond the current horizon.
Total raised: $58M
Investors 6
| Date | Name | Website |
| - | Mirai Crea... | mirai.spar... |
| - | Berkeley S... | skydeck.be... |
| - | ITOCHU Tec... | techv.co.j... |
| - | Real Tech ... | en.realtec... |
| - | MBC BioLab... | mbcbiolabs... |
| - | J-Startup | j-startup.... |
Funding Rounds 2
| Date | Series | Amount | Investors |
| 02.09.2024 | Series C | $32M | - |
| 19.05.2021 | Series B | $26M | - |
Mentions in press and media 14
| Date | Title | Description |
| 02.09.2024 | ThinkCyte's Bold Leap: $32 Million to Revolutionize Life Sciences | In the bustling world of biotechnology, ThinkCyte is making waves. The company recently secured $32 million in Series C funding, a significant boost for its innovative endeavors. This funding round, which included an additional $15 million ... |
| 02.09.2024 | ThinkCyte Raises $15M; Closes $32M Series C | ThinkCyte, a Tokyo, Japan- and Redwood City, CA-based biotechnology company developing scientific instruments, raised raised an additional $15M in the extension round, bringing the total Series C to $32M. The round was led by Japan Green In... |
| 31.08.2024 | ThinkCyte Secures $32 million in Series C Funding to Drive Global Expansion of VisionSort™ | TOKYO and REDWOOD CITY, Calif., Aug. 31, 2024 /PRNewswire/ -- ThinkCyte today announced the successful completion of its Series C funding round. Including the equity financing secured last November, the company raised an additional $15 mill... |
| 06.05.2024 | ThinkCyte Launches New Website and Showcases VisionSortTM at Global Events | TOKYO, May 7, 2024 /PRNewswire/ -- ThinkCyte today announced that it will be presenting at three major international scientific conferences in the first week of May and the launch of its updated website. The company will have a presence at ... |
| 01.04.2024 | ThinkCyte advances biopharma phenotypic drug discovery programs with publication and presentation milestones | TOKYO, April 1, 2024 /PRNewswire/ -- ThinkCyte today announced the publication of a paper in the March issue of Cell Reports Methods on a new method for high-throughput drug discovery. Together with a joint research group including investig... |
| 09.01.2024 | ThinkCyte Launches Partnering Platform | ThinkCyte today announced the launch of its new partnering program for the biopharmaceutical and diagnostics industry. TOKYO, JAPAN, January 9, 2024 /EINPresswire.com/ -- ThinkCyte today announced the launch of its new partnering program fo... |
| 12.10.2023 | NEDO「ディープテック・スタートアップ支援基金／ディープテック・スタートアップ支援事業」に採択 | シンクサイト株式会社は、国立研究開発法人新エネルギー・産業技術総合開発機構（NEDO）の「ディープテック・スタートアップ支援基金／ディープテック・スタートアップ支援事業」（以下、「DTSU」）のDMPフェーズ（量産化実証）に採択されました。 NEDOのDTSUは、技術の確立や事業化、社会実装までに長期の研究開発と大規模な資金を要するものの、国もしくはグローバルレベルで対処すべき社会課題を解決し得る、革新的な技術の研究開発に取り組む「ディープテック・スタートアップ」に対し、実... |
| 19.05.2021 | ThinkCyte Secures $26M in Series B Funding | ThinkCyte, a Tokyo, Japan-based company focusing on the development of novel cell therapy, drug discovery and diagnostic platforms, raised $26m in Series B funding. The round was led by SPARX Group, Sysmex Corporation, Sumitomo Mitsui Trust... |
| 19.05.2021 | ThinkCyte Secures $26 million in Series B Financing | TOKYO, May 19, 2021 /PRNewswire/ -- ThinkCyte, Inc., a company focusing on the development of novel cell therapy, drug discovery and diagnostic platforms, announced today the completion of a $26 million (JPY 2.85 billion) Series B financing... |
| 19.05.2021 | ThinkCyte Secures $26 million in Series B Financing |
Show more